The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial

被引：0
|
作者：
Chris Dalby
Tomasz Polanowski
Thomas Larsson
Lars Borgström
Staffan Edsbäcker
Tim W Harrison
机构：
[1] Nottingham University,Respiratory Medicine Unit
[2] AstraZeneca R&D,undefined
来源：
Respiratory Research | / 10卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Budesonide; Fluticasone; Fluticasone Propionate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 11 条
  • [1] The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial
    Dalby, Chris
    Polanowski, Tomasz
    Larsson, Thomas
    Borgstrom, Lars
    Edsbacker, Staffan
    Harrison, Tim W.
    RESPIRATORY RESEARCH, 2009, 10
  • [2] Bronchodilator effect of an inhaled combination therapy with salmeterol plus fluticasone and formoterol plus budesonide in patients with COPD
    Cazzola, M
    Santus, P
    Di Marco, F
    Boveri, B
    Castagna, F
    Carlucci, P
    Matera, MG
    Centanni, S
    RESPIRATORY MEDICINE, 2003, 97 (05) : 453 - 457
  • [3] Effect of Inhaled Mometasone/Formoterol vs Inhaled Fluticasone/Salmeterol on Peripheral Airway Function in Asthma Patients: A Randomized Open Label Trial
    Petnak, Tananchai
    Pornsuriysak, Prapaporn
    Boonsarngsuk, Viboon
    Amornputtisathaporn, Naparat
    Kawamatawong, Theerasuk
    CHEST, 2016, 150 (04) : 16A - 16A
  • [4] Inhaled fluticasone propionate (FP) restores angiogenesis in the airway lamina propria of current smokers with COPD: A randomized controlled trial
    Sohal, Sukhwinder Singh
    Soltani, Amir
    Reid, David
    Muller, Hans Konrad
    Wood-Baker, Richard
    Walters, Eugene Haydn
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids
    Hampel, Frank C.
    Martin, Paula
    Mezzanotte, William S.
    JOURNAL OF ASTHMA, 2008, 45 (04) : 265 - 272
  • [6] Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy
    Hozawa, Soichiro
    Terada, Michikazu
    Hozawa, Maki
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 27 (02) : 190 - 196
  • [7] Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non-frequently exacerbating COPD patients: The FLASH randomized controlled trial
    Frith, Peter A.
    Ashmawi, Samiha
    Krishnamurthy, Srikanth
    Gurgun, Alev
    Hristoskova, Sashka
    Pilipovic, Virginia
    Hamann, Anna Marie
    Backer, Arthur
    Olsson, Petter
    Kostikas, Konstantinos
    Diaz, Dina V.
    RESPIROLOGY, 2018, 23 (12) : 1152 - 1159
  • [8] Polyphenol Bioavailability and Plasma Antiradical Capacity in Healthy Subjects after Acute Intake of Pigmented Rice: A Crossover Randomized Controlled Clinical Trial
    Vitalini, Sara
    Sardella, Andrea
    Fracassetti, Daniela
    Secli, Rita
    Tirelli, Antonio
    Lodi, Giovanni
    Carrassi, Antonio
    Varoni, Elena Maria
    Iriti, Marcello
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 10
  • [9] Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE
    Saito, Takefumi
    Takeda, Akinori
    Hashimoto, Katsuji
    Kobayashi, Akihiro
    Hayamizu, Tomoyuki
    Hagan, Gerald W.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2393 - 2404
  • [10] Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE (vol 10, pg 2393, 2015)
    Saito, T.
    Takeda, A.
    Hashimoto, K.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1031 - 1033
12